0001567619-18-002345.txt : 20180910 0001567619-18-002345.hdr.sgml : 20180910 20180910110303 ACCESSION NUMBER: 0001567619-18-002345 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180615 FILED AS OF DATE: 20180910 DATE AS OF CHANGE: 20180910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Geiger Uri CENTRAL INDEX KEY: 0001467361 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51481 FILM NUMBER: 181061777 MAIL ADDRESS: STREET 1: 221 LATHROP WAY, SUITE I CITY: SACRAMENTO STATE: CA ZIP: 95815 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: STRATA Skin Sciences, Inc. CENTRAL INDEX KEY: 0001051514 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 133986004 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 LAKESIDE DRIVE STREET 2: SUITE 100 CITY: HORSHAM STATE: PA ZIP: 19044 BUSINESS PHONE: 215-619-3200 MAIL ADDRESS: STREET 1: 100 LAKESIDE DRIVE STREET 2: SUITE 100 CITY: HORSHAM STATE: PA ZIP: 19044 FORMER COMPANY: FORMER CONFORMED NAME: MELA SCIENCES, INC. /NY DATE OF NAME CHANGE: 20100504 FORMER COMPANY: FORMER CONFORMED NAME: ELECTRO OPTICAL SCIENCES INC /NY DATE OF NAME CHANGE: 19971216 4 1 doc1.xml FORM 4 X0306 4 2018-06-15 0 0001051514 STRATA Skin Sciences, Inc. SSKN 0001467361 Geiger Uri C/O STRATA SKIN SCIENCES, INC. 100 LAKESIDE DRIVE, SUITE 100 HORSHAM PA 19044 1 0 0 0 SSKN Common Stock 2018-06-15 4 J 0 75590 1.09 A 12122627 I see footnote 6/15/18 the reporting person was entitled to receive 75,590 shares of the common stock pursuant to a "retained risk" provision in the Securities Purchase Agreement between the Company and Accelmed Growth Partners, L.P. dated 5/29/18 ("Purchase Agreement"). Purchase Agreement provided that the purchaser would receive additional shares of common stock in the event of certain contingent expense events, one of which was determined to have occurred on 6/15/18, resulted in the purchaser acquired additional shares. The number of shares issuable pursuant to that provision, determined on 6/15/18 pursuant to a formula set forth in the Purchase Agreement provided that, for purposes of determining the number of shares issuable, the common stock would be valued at $1.09 per share, which was the purchase price of the common stock in the Purchase Agreement. Consists of 12,112,627 shares of the common stock held by Accelmed Growth Partners, L.P. Uri Geiger is the controlling member and managing partner of Accelmed Growth Partners (AGP) Limited, which is the general partner of Accelmed Growth Partners (GP), L.P., which is the general partner of Accelmed Growth Partners, L.P. and as a result Uri Geiger may be deemed to beneficially own the shares of common stock held by Accelmed Growth Partners, L.P. Uri Geiger is the controlling shareholder and managing partner of Accelmed Growth Partners Management Ltd., which has certain voting and dispositive power over the 12,112,627 shares of common stock owned by Accelmed Growth Partners, L.P. pursuant to a management agreement, and as a result Uri Geiger may be deemed to beneficially own the shares of the common stock held by Accelmed Growth Partners, L.P. /s/ Uri Geiger 2018-09-10